Anticoagulant drugs are advancing in clinical application and development for thromboembolic disease, alongside evolving market trends in China and globally.
This review provides an overview of the epidemiology of thromboembolic disease and the development and market analysis of anticoagulant drugs.
Absolute Event Rate: 0% vs 0%
This review describes epidemiology of thromboembolic disease in China and abroad, evaluates trends in the development of anticoagulant drugs, and analyzes the market situation based on large amounts of accumulated data. Specifically, we describe advances in clinical application of anticoagulants and analyze the most commonly used anticoagulants in the market systematically.
Fan et al. (Thu,) reported a other. Anticoagulant drugs are advancing in clinical application and development for thromboembolic disease, alongside evolving market trends in China and globally.